<DOC>
	<DOCNO>NCT00251576</DOCNO>
	<brief_summary>A-Phase : Evaluating patient chest pain receiving approve drug , estimate effectiveness one type blood thinner compare another type blood thinner . Z-Phase : To evaluate early treatment patient long term chest pain ( use approve drug 30 day , follow increase dose drug ) compare patient ( treat diet 4 month placebo follow diet approved drug ) patient experience acute chest pain heart attack .</brief_summary>
	<brief_title>Aggrastat Zocor ( AtoZ ) - Use Two Approved Drugs Treat Patients Who Have Experienced Chest Pain Heart Attack ( 0733-180 )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>APhase : Chest pain rest 10 minute , EKG change elevate cardiac blood work ZPhase : elevate cholesterol , plus least one risk factor ( &gt; 70 year old , diabetes , history prior heart blood vessel disease , chest pain EKG change , elevation cardiac lab work positive cardiac test , least 2 heart vessel block [ one &gt; = 75 % one &gt; = 50 % ] ) APhase : use specific cardiac drug , high risk bleeding , prior blood clot disorder ZPhase : elevation certain cardiac blood test , significant heart damage catheterization , plan cardiac surgery specific cardiac drug low cholesterol level , within 6 week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>